|
|
Article: Quadramet gives pain relief of bone metastases.
- Article from:
- Disease State Management
- Article date:
- January 1, 1998
CopyrightCOPYRIGHT 1998 AHC Media LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Quadramet gives pain relief of bone metastases
Study shows increased survival rates
A single dose of Quadramet (samarium Sm 153 lexidronam injection) can offer significant relief for cancer patients suffering from painful bone metastases, according to a study published recently in the European Journal of Cancer (Vol. 33, pp. 1,583-1,591, 1997). The drug also prolonged the survival of some breast cancer patients in the seven-site European study.
Quadramet, from Princeton, NJ-based Cytogen Corp., was approved in March by the Rockville, MD-based Food and Drug Administration for the relief of pain in patients with confirmed osteoblastic metastatic ...